Here is a summary of fitness briefs.
BioNTech to Invest $43 Million in German Facility for mRNA Vaccine Building Block
BioNTech will invest 40 million euros ($43 million) in a new facility in Germany that will allow it to produce a portion of the mRNA-based drugs, the German pharmaceutical company said on Thursday. German Chancellor Olaf Scholz, who visited the Marburg facility on Thursday, 90 km (55. 9 miles) north of Frankfurt, welcomed the investment.
GSK gives some clues about cabinet replacement plans
On Wednesday, GSK CEO Emma Walmsley made replenishing the drugmaker’s vaccine and therapeutics her number one priority. But analysts were disappointed that she didn’t provide more main points on how she and her control team plan to locate the company’s next suite of blockbuster drugs.
WHO draft pandemic agreement boosts equity to repeat COVID ‘failure’
Governments would likely have to reserve medicines and vaccines at the World Health Organization for distribution to poorer countries to avoid a repeat of the “catastrophic failure” of the COVID-19 pandemic, according to a first draft of a global agreement on the pandemic. One of the top concrete proposals in the draft agreement released by Reuters on Wednesday includes a measure to reserve 20 percent of all tests, vaccines or remedies developed for use in poorer countries.
Canadian province tries to decriminalize to combat overdose crisis
The western Canadian province of British Columbia on Tuesday unveiled a three-year pilot program aimed at avoiding prosecution of others for transporting small amounts of heroin, methamphetamine, ecstasy or crack as part of an effort to combat a drug overdose crisis. BEFORE JC. It accounts for about a third of the 32,000 overdose and trafficking deaths nationwide since 2016, according to official data. The province declared the drug overdose a public fitness emergency that year.
In a crisis healthcare formula, the UK spotlight suffers
In April 2021, Garry Cogan felt a slow, burning pain gradually appearing in his right arm. It was the beginning of an attack on the primary center that doctors say could shorten his life for decades without a quick triple step. Nearly two years later, Cogan is still waiting for an operation from the UK’s battered fitness service, one of millions who will suffer as it collapses under the weight of an aging population, lack of investment and the COVID-19 pandemic.
The case of mad cow disease in Holland is a variant of old age
A case of mad cow disease discovered on a Dutch farm is the variant of old age that is not harmful to public health, the Agriculture Ministry said on Wednesday. The infection was detected in a dead cow on 30 January in the province of South Holland in the Netherlands.
Siemens Healthineers confirms outlook despite first-quarter earnings drop
Siemens Healthineers on Thursday showed its full-year outlook despite a decline in quarterly profit due to weak demand in China as it recorded strong order expansion in the first quarter. The company has maintained its comparable cash outlook. solid in a diversity from a 1% decrease to a 1% increase in fiscal 2023 compared to €21. 7 billion last year.
Mailing abortion pills could break the law, Republican prosecutors tell pharmacies
An organization of 20 Republican state attorneys general told Walgreens Boots Alliance Inc. and CVS Health Corp on Wednesday that risked breaking federal and state law if they distributed the abortion drug mifepristone by mail. The decision, announced through Missouri Attorney General Andrew Bailey, comes weeks after the U. S. Food and Drug Administration launched a decision to help Missouri Attorney General Andrew Bailey. The U. S. Food and Drug Administration for the first time allowed retail pharmacies to dispense mifepristone, adding by mail, as long as they meet special qualified protection standards for the drug.
The U. S. FDA U. S. Eliminates COVID Testing Requirements for Pfizer and Merck Pills
The U. S. Food and Drug AdministrationThe U. S. Food and Drug Administration on Wednesday eliminated the need for a positive test for Pfizer Inc and Merck’s COVID-19 treatments.
The U. S. FDA U. S. Approves GSK’s Anti-Anemia Drug for Dialysis Patients
The U. S. Food and Drug Administration (FDA) on Wednesday approved GSK Plc’s drug as the first oral remedy for anemia caused by chronic kidney disease in adults who have been on dialysis for at least 4 months. An accumulation of thrombotic vascular events, including death, central attack, stroke, and blood clots in the lungs, legs, or dialysis access site. Warnings and precautions also come with a threat of hospitalization for central failure, worsening blood pressure buildup, abdominal erosions, and gastrointestinal bleeding.
(With input from agencies. )